Entheon Biomedical Corp. Provides Update on Subsidiary, HaluGen Life Sciences

Vancouver, British Columbia–(Newsfile Corp. – February 24, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Vancouver, British Columbia–(Newsfile Corp. – February 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC: ENTBF)…

Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development

Vancouver, British Columbia–(Newsfile Corp. – February 16, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink:…

Entheon Biomedical Hires ClearTV Executive as VP of Digital Experience Entertainment Veteran Jonna Birgans to Oversee Digital and VR Content Development

Vancouver, British Columbia–(Newsfile Corp. – February 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC PINK:…

Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments

Vancouver, British Columbia–(Newsfile Corp. – February 2, 2021) –  Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF)…

Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development

Vancouver, British Columbia–(Newsfile Corp. – January 19, 2021) –  Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Corp. Announces Acquisition of HaluGen Life Sciences Inc.

Vancouver, British Columbia–(Newsfile Corp. – January 14, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Engages Star Finance GmbH for Investor Relations

Vancouver, British Columbia–(Newsfile Corp. – January 12, 2021) –  Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Engages World Renowned Media Personality DJ Skee, AKA Scott Keeney, as Media Advisor

Vancouver, British Columbia–(Newsfile Corp. – January 11, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC

Vancouver, British Columbia–(Newsfile Corp. – January 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific

Vancouver, British Columbia–(Newsfile Corp. – December 4, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…

Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021

Vancouver, British Columbia–(Newsfile Corp. – December 1, 2020) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1)…